Evropska unija -
slovenščina -
EMA (European Medicines Agency)
yesafili
viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmologi - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.
Evropska unija -
slovenščina -
EMA (European Medicines Agency)
zaltrap
sanofi winthrop industrie - aflibercept - kolorektalne neoplazme - antineoplastična sredstva - zdravljenje metastatskega kolorektalnega raka (mcrc).
Evropska unija -
slovenščina -
EMA (European Medicines Agency)
eylea
bayer ag - aflibercept - wet macular degeneration; macular edema; diabetes complications - oftalmologi - eylea je primerna za odrasle, za zdravljenje:neovascular (mokro) starostna degeneracija rumene pege (amd);vida zaradi degeneracija edem sekundarnega do mrežnice vene (veja rvo ali centralne rvo);vida zaradi diabetično degeneracija edem (dme);vida zaradi kratkovidna choroidal neovascularisation (kratkovidna cnv).
Evropska unija -
slovenščina -
EMA (European Medicines Agency)
vabysmo
roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - oftalmologi - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).
Evropska unija -
slovenščina -
EMA (European Medicines Agency)
beovu
novartis europharm limited - brolucizumab - mokra makularna degeneracija - oftalmologi - beovu je navedeno pri odraslih za zdravljenje neovascular (mokro) starostna degeneracija rumene pege (amd).